AbbVie Unit Launches Patent Suit Over Cancer Drug
By Adam Lidgett ( June 15, 2023, 8:44 PM EDT) -- AbbVie's Pharmacyclics unit has alleged in a new suit that its recently issued patent relating to its cancer drug Imbruvica is being infringed by a BeiGene product that got approval from federal regulators earlier this year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.